SEP 16, 2021 9:40 AM PDT

Leveraging TMT multiplexing for increased throughput in protein-centric characterizations of heterogeneity at the single cell level

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

In recent years, life science research has experienced a significant shift, moving away from conducting bulk cell interrogation towards single-cell analysis. It is only through single-cell analysis that a complete understanding of cellular heterogeneity, and the interplay between various cell types fundamental to specific biological phenotypes can be achieved. The blood system is a prime example of such a complex hierarchy, where Hematopoietic stem cells are the origin of all cell lineages contained therein. Acute myeloid leukemia (AML), a perturbed state of hematopoiesis, is also hierarchically organized, with leukemia stem cells at the apex. Successful eradication of AML will likely depend on specific targeting of these tumour-initiating cells, in turn requiring their molecular characterization.

We have spent the past few years optimizing a proteomics workflow for analyzing single cells using Mass Spectrometry (scMS). Through isobaric labeling using latest-generation TMTPro reagents, we ensure highest possible cell throughput, bringing in-depth characterizations of >10,000 single cells within reach. We demonstrate both through pre-enrichment of cell populations and through a non-enriched unbiased approach that our workflow enables the exploration of cellular heterogeneity within healthy and aberrant blood hierarchies. We leverage a combination of fluorescence-activated cell sorting, automated liquid handling, next-generation chromatography, state-of-the-art MS instrumentation and complex data analysis workflows to provide a comprehensive suite of scMS tools. Combined, our workflow strikes a careful balance between cell throughput, proteome depth, quantitative accuracy and ease-of-implementation, and demonstrates the power of implementing global single-cell proteomics studies in labs across the world.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources